MAP kinase modulation in squamous cell carcinoma of the oral cavity

Anticancer Research

Volumn 29, Issue 1, 2009, Pages 303-308

  Aguzzi, Alessia ^a   Maggioni, Daniele ^a   Nicolini, Gabriella ^a   Tredici, Giovanni ^a   Gaini, Renato Maria ^a   Garavello, Werner ^a,b  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Immunoblotting; MAPK; Oral cancer; Phospho ERK; Squamous sell carcinoma

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; MOUTH NEOPLASMS; PHOSPHORYLATION;

EID: 61449152136     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin 56(2): 106-130, 2006.
2. Rogers SJ, Harrington KJ, Rhys-Evans P, O-Charoenrat P and Eccles SA: Biological significance of c-erbB family oncogenes in head and neck cancer. Cancer Metastasis Rev 24(1): 47-69, 2005.
3. Kademani D: Oral cancer. Mayo Clin Proc 82(7): 878-887, 2007.
4. Choong N and Yokes E: Expanding role of the medical oncologist in the management of head and neck cancer. CA Cancer J Clin 58(1): 32-53, 2008.
5. Tokman B, Gulteikin SE, Sezer C and Alpar R: The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system. Saudi Med J 25(12): 1922-1930, 2004.
6. Raybaud H, Odin G, Fafet A, Santini J and Monteil RA: Genetic alteration in oral and head and neck squamous cell carcinomas: analysis of international literature. Pathologie-Biologie 51(3): 176-184, 2003.
7. Diniz-Freitas M, Garcia-Caballero T, Antunez-Lopez J, Gandara-Rey JM and Garcia Garcia A: Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma. Oral Diseases 13(3): 285-290, 2007.
8. Scartozzi M, Bearzi I, Berardi R, Mandolesi A, Pierantoni C and Cascinu S: Epidermal growth factor receptor (EGFR) downstream signaling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options. Br J Cancer 97(2): 92-97, 2007.
9. Kato Y, Tapping RI, Huang S, Watson MH, Ulevitch RJ and Lee JD: Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 395(6703): 713-716, 1998.
10. Owens DM and Keyse SM: Differential regulation of MAP kinase signaling by dual-specificity protein phosphatases. Oncogene 26(22): 3203-3213, 2007.
11. Schreck R and Rapp UR: Raf kinases: oncogenes and drug discovery. Int J Cancer 119(10): 2261-2271, 2006.
12. Schweyer S, Bachern A, Bremmer F, Steinfelder HJ, Soruri A, Wagner W, Pottek T, Thelen P, Hopker WW, Radzun HJ and Fayyazi A: Expression and function of protein phosphatase PP2A in malignant testicular germ cell tumours. J Pathol 213(1): 72-81, 2007.
13. Djeu JY, Jiang K and Wei S: A view to a kill: signals triggering cytotoxicity. Clin Cancer Res 8(3): 636-640, 2002.
14. Raman M, Chen W and Cobb MH: Differential regulation and properties of MAPKs. Oncogene 26(22): 3100-3112, 2007.
15. Katz M, Amit I and Yarden Y: Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta 1773(8): 1161-1176, 2007.
16. Garavello W, Nicolini G, Aguzzi A, Maggioni D, Leone BE, Viganò P, Gaini RM and Tredici G: Selective reduction of extracellular signal-regulated protein kinase (ERK) phosphorylation in squamous cell carcinoma of the larynx. Oncol Report 16(3): 479-484, 2006.
17. Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S and Ronai Z: Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11(5): 447-460, 2007.
18. Zhuang L, Lee CS, Scolyer RA, McCarthy SW, Palmer AA, Zhang XD, Thompson JF, Bron LP and Mersey P: Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma. J Clin Pathol 58(11): 1163-1169, 2005.
19. Fang JY and Richardson BC: The MAPK signaling pathways and colorectal cancer. Lancet Oncol 6(5): 322-327, 2005.
20. Liang B, Wang S, Zhu XG, Yu YX, Cui ZR and Yu YZ: Increased expression of mitogen-activated protein kinase and its upstream regulation signal in human gastric cancer. World J Gastroenterol 11(5): 623-628, 2005.
21. Tosi L, Rinaldi E, Carinci F, Farina A, Pastore A, Pelucchi S, Cassano L, Evangelisti R, Carinci P and Volinia S: Akt, protein kinase C, and mitogen-activated protein kinase phosphorylation status in head and neck squamous cell carcinoma. Head Neck 27(2): 130-137, 2005.
22. Paweletz CP, Charboneau L, Bichsel VE, Simone NL, Chen T, Gillespie JW, Emmert-Buck MR, Roth MJ, Petricoin III EF and Liotta LA: Reverse-phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20(16): 1981-1989, 2001.
23. Mishima K, Yamada E, Masui K, Shimokawara T, Takayama K, Sugimura M and Ichijima K: Overexpression of the ERK/MAP kinases in oral squamous cell carcinoma. Mod Pathol 11(9): 886-891, 1998.
24. Albanell J, Codony-Servat J, Rojo F, Del Campo JM, Sauleda S, Anido J, Raspall G, Giralt J, Rosello J, Nicholson RI, Mendelsohn J and Baselga J: Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Cancer Res 61(17): 6500-6510, 2001.
25. Wang L, Liu T, Nishioka M, Aguirre RL, Win SS and Okada N: Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation. Oral Oncol 42(6): 625-631, 2006.
26. Engelbrecht AM, Gebhardt S and Louw L: Ex vivo study of MAPK profiles correlated with parameters of apoptosis during cervical carcinogenesis. Cancer Lett 235(1): 93-99, 2006.
27. Uzgare AR, Kaplan PJ and Greenberg NM: Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer. Prostate 55(2): 128-139, 2003.
28. Chambard JC, Lefloch R, Pouysségur J and Lenormand P: ERK implication in cell cycle regulation. Biochim Biophys Acta 1773(8): 1299-1310, 2007.
29. York RD, Yao H, Dillon T, Ellig CL, Eckert SP, Mc Cleskey EW and Stork PJ: Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392(6676): 622-626, 1998.
30. Frey RS and Mulder KM: Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells. Cancer Res 57(4): 628-633, 1997.
31. Simon C, Hicks MJ, Nemechek AJ, Mehta R, O'Malley BW Jr, Goepfert H, Flaitz CM and Boyd D: PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma. Br J Cancer 80(9): 1412-1419, 1999.
32. Chen PN, Hsieh YS, Chiang CL, Chiou HL, Yang SF and Chu SC: Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J Dent Res 85(3): 220-225, 2006.
33. Patel V, Ramesh A, Traicoff JL, Baibakov G, Emmert-Buck MR, Gutkind JS and Knezevic V: Profiling EGFR activity in head and neck squamous cell carcinoma by using a novel layered membrane Western blot technology. Oral Oncol 41(5): 503-508, 2005.
34. Mizumoto Y, Kyo S, Mori N, Sakaguchi J, Ohno S, Maida Y, Hashimoto M, Takakura M and Inoue M: Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis. Cancer Sci 98(5): 652-58, 2007.
35. Matsuura K, Nohno Y, Hijiya N, Uchida T, Tsukamoto Y and Moriyama M: Extracellular signal-regulated protein kinase is activated in cervical intraepithelial neoplasms but inactivated in invasive cervical carcinoma. Pathol Int 56(7): 368-374, 2006.
36. Li DW, Liu JP, Mao YW, Xiang H, Wang J, Ma WY, Dong Z, Pike HM, Brown RE and Reed JC: Calcium-activated RAF/MEK/ERK signaling pathway mediates p53-dependent apoptosis and is abrogated by alpha B-crystallin through inhibition of RAS activation. Mol Biol Cell 16(9): 4437-4453, 2005.
37. Lee SK, Jang HJ, Lee HJ, Lee J, Jeon BH, Jun CD, Lee SK and Kim EC: p38 and ERK MAP kinase mediate iron chelator-induced apoptosis and suppressed differentiation of immortalized and malignant human oral keratinocytes. Life Sci 79(15): 1419-1427, 2006.